Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Garret Cullen

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Inflammatory Bowel Diseases|September 3, 2015
Heightened Expression of CD39 by Regulatory T Lymphocytes Is Associated with Therapeutic Remission in Inflammatory Bowel DiseaseDavid J Gibson, Louise Elliott, Edel McDermott, et al.
Journal of Crohn'S & Colitis|October 1, 2015
DNA Methylation Profiling in Inflammatory Bowel Disease Provides New Insights into Disease PathogenesisEdel McDermott, Elizabeth J Ryan, Miriam Tosetto, et al.
Journal of Crohn'S & Colitis|February 17, 2022
Reduced Serological Response to COVID-19 Vaccines in Patients with IBD is Further Diminished by TNF Inhibitor Therapy; Early Results of the VARIATION study [VAriability in Response in IBD Against SARS-COV-2 ImmunisatiON]Jayne Doherty, Neil O Morain, Roisin Stack, et al.
Frontline Gastroenterology|October 26, 2020
Comparison of medium to long-term outcomes of acute severe ulcerative colitis patients receiving accelerated and standard infliximab inductionDavid J Gibson, Jayne Doherty, Mairead McNally, et al.
Virchows Archiv : an International Journal of Pathology|May 12, 2026
Histopathological characteristics of screen-detected colorectal cancersCian Ward, Mary O'Reilly, Ciara Guerin, et al.
Inflammatory Bowel Diseases|April 13, 2026
Transitioning to adult care for patients with IBD: the impact of a structured IBD transition program on service engagementJayne Doherty, Ciaran Hurley, Parker Girod, et al.
Journal of Crohn'S & Colitis|April 5, 2023
Reduced Serological Response to COVID-19 Booster Vaccine is Associated with Reduced B Cell Memory in Patients With Inflammatory Bowel Disease; VARIATION [VAriability in Response in IBD AgainsT SARS-COV-2 ImmunisatiON]Jayne Doherty, Neil O'Morain, Roisin Stack, et al.
European Journal of Gastroenterology & Hepatology|June 8, 2018
Golimumab effectiveness and safety in clinical practice for moderately active ulcerative colitisJim O'Connell, Cathy Rowan, Roisin Stack, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 22, 2024
Effectiveness, safety, and cost of combination advanced therapies in inflammatory bowel diseaseCathy McShane, Rachel Varley, Anne Fennessy, et al.
Scandinavian Journal of Gastroenterology|June 17, 2020
Irish data on the safety and efficacy of vedolizumab in the treatment of inflammatory bowel diseaseCiaran Judge, Neasa McGettigan, Timothy Ryan, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Inflammatory Bowel Diseases|September 3, 2015
Heightened Expression of CD39 by Regulatory T Lymphocytes Is Associated with Therapeutic Remission in Inflammatory Bowel DiseaseDavid J Gibson, Louise Elliott, Edel McDermott, et al.
Journal of Crohn'S & Colitis|October 1, 2015
DNA Methylation Profiling in Inflammatory Bowel Disease Provides New Insights into Disease PathogenesisEdel McDermott, Elizabeth J Ryan, Miriam Tosetto, et al.
Journal of Crohn'S & Colitis|February 17, 2022
Reduced Serological Response to COVID-19 Vaccines in Patients with IBD is Further Diminished by TNF Inhibitor Therapy; Early Results of the VARIATION study [VAriability in Response in IBD Against SARS-COV-2 ImmunisatiON]Jayne Doherty, Neil O Morain, Roisin Stack, et al.
Frontline Gastroenterology|October 26, 2020
Comparison of medium to long-term outcomes of acute severe ulcerative colitis patients receiving accelerated and standard infliximab inductionDavid J Gibson, Jayne Doherty, Mairead McNally, et al.
Virchows Archiv : an International Journal of Pathology|May 12, 2026
Histopathological characteristics of screen-detected colorectal cancersCian Ward, Mary O'Reilly, Ciara Guerin, et al.
Inflammatory Bowel Diseases|April 13, 2026
Transitioning to adult care for patients with IBD: the impact of a structured IBD transition program on service engagementJayne Doherty, Ciaran Hurley, Parker Girod, et al.
Journal of Crohn'S & Colitis|April 5, 2023
Reduced Serological Response to COVID-19 Booster Vaccine is Associated with Reduced B Cell Memory in Patients With Inflammatory Bowel Disease; VARIATION [VAriability in Response in IBD AgainsT SARS-COV-2 ImmunisatiON]Jayne Doherty, Neil O'Morain, Roisin Stack, et al.
European Journal of Gastroenterology & Hepatology|June 8, 2018
Golimumab effectiveness and safety in clinical practice for moderately active ulcerative colitisJim O'Connell, Cathy Rowan, Roisin Stack, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 22, 2024
Effectiveness, safety, and cost of combination advanced therapies in inflammatory bowel diseaseCathy McShane, Rachel Varley, Anne Fennessy, et al.
Scandinavian Journal of Gastroenterology|June 17, 2020
Irish data on the safety and efficacy of vedolizumab in the treatment of inflammatory bowel diseaseCiaran Judge, Neasa McGettigan, Timothy Ryan, et al.
Pageof 7